With a market capitalization (market cap) of $1.41B — a measure of how much the company is worth — Windward Bio Group AG ranks #2,186 among the 2,418 companies tracked, and 305th in Healthcare as of November 18, 2026. Shares trade at $24.32, down 5.61% on the day.
As of November 18, 2026 · Prices may be delayed
of 2,418 tracked
Market-cap change uses historical capitalization records. Share-price returns are a different series and can differ when the share count changes. Returns below show the total change over each period. Use the CAGR calculator to calculate an annualized return. CAGR calculator. Market cap vs. stock price.
Listed less than one month ago
Listed less than one year ago
Listed less than one month ago
Listed less than one year ago
Listed less than six months ago
Listed this year; no prior year-end value to compare
Listed less than five years ago
Year-end values and the chart both come from historical market-cap records, not from applying today's share count to past prices. Latest historical observation November 17, 2026. The headline market cap is from the ranking update on November 18, 2026.
| Year | As of | Market cap | Annual change | Share-price close |
|---|---|---|---|---|
| 2026Latest available | Nov 17, 2026 | $397.76M | — | $25.76 |
Last observation of each calendar year from historical market-cap records. The current year is through the latest date, not a completed year-end. Share-price close is the matching session for context — we do not rebuild cap from today's share count.
Ranking figure $1.41B as of November 18, 2026.
Market cap = share price × shares outstanding.
Windward Bio Group AG's ranking market cap is the reported market cap from the latest ranking update, with a share price of $22.16 as of November 18, 2026. Charts and the year-end table use a separate historical market-cap series, last observed at $397.76M on November 17, 2026. See how the ranking works.
The ranking snapshot ($1.41B as of November 18, 2026) is FMP company-screener market cap. The historical observation ($397.76M on November 17, 2026) is FMP historical-market-capitalization for the same ticker. The live quote market cap ($1.29B) is a third FMP field, not a reason to overwrite either series. This page does not replace one series with the other.
Current shares outstanding are unavailable from the latest quote. Shares outstanding vs. float.
Book equity: assets minus liabilities on the latest annual report.
Book equity (net worth) data unavailable
Book value / share data unavailable
P/E (reported, FY) data unavailable
EPS (basic, FY) data unavailable
Dividend yield data unavailable
Gross margin data unavailable
Operating margin data unavailable
Enterprise value data unavailable
EV / EBITDA data unavailable
EV / Sales data unavailable
Price / book data unavailable
Price / sales data unavailable
Earnings yield data unavailable
Free cash flow yield data unavailable
Revenue data unavailable
Gross profit data unavailable
Operating income data unavailable
EBITDA data unavailable
Net income data unavailable
EPS (diluted, FY) data unavailable
Weighted-average shares (FY) data unavailable
Quote as of . Prices may be delayed. Day figures refer to the quote's trading session.
Latest quote: $22.16. The headline price of $24.32 is from the ranking update on Nov 18, 2026. These updates can differ in timing.
Largest U.S.-listed companies in the same sector. These companies may serve different markets.
| Rank | Company | Market cap | 1D |
|---|---|---|---|
| #11 | Eli Lilly and Company LLY | $1.31T | -1.68% |
| #19 | Johnson & Johnson JNJ | $664.04B | -1.00% |
| #23 |
Operates as a holding company whose subsidiaries develops and commercializes therapeutics
Summary from the company profile (Financial Modeling Prep).
Visit websiteAs of November 18, 2026, Windward Bio Group AG (WWB) is worth $1.41B — that is its market capitalization, the total value of its outstanding shares on MarketCapLens.
A company’s net worth is its shareholders’ equity: assets minus liabilities on the balance sheet. That is book equity, not market cap. Book equity is blank on this page when annual book value per share is missing. Market cap is the market value of the outstanding shares. As of November 18, 2026, its market cap is $1.41B. Book equity is an accounting remainder; market cap is a trading value. Neither is a person’s net worth.
Windward Bio Group AG ranks #2,186 among the 2,418 companies tracked on MarketCapLens. In Healthcare it ranks #305 of 353.
Financial figures are annual and labeled with their fiscal year (FY). Current-price P/E uses the latest available share price and annual earnings per share.
Net margin data unavailable
Return on equity data unavailable
Debt / equity data unavailable
Current ratio data unavailable
Return on assets data unavailable
Return on invested capital data unavailable
| $508.92B |
| -1.58% |
| #31 | Merck & Co., Inc. MRK | $342.3B | -3.09% |
| #35 | UnitedHealth Group Incorporated UNH | $318.26B | -8.69% |
| #38 | Novartis AG NVS | $294.55B | -1.99% |
Companies immediately above and below in the overall ranking. They may be in a different sector.
| Rank | Company | Market cap | 1D |
|---|---|---|---|
| #2183 | UroGen Pharma Ltd. URGN | $1.43B | -2.53% |
| #2184 | Alkami Technology, Inc. ALKT | $1.42B | -1.63% |
| #2185 | Permian Basin Royalty Trust PBT | $1.41B | -2.10% |
| #2187 | ICF International, Inc. ICFI | $1.41B | +0.70% |
| #2188 | Ellington Financial Inc. EFC | $1.41B | +1.69% |
| #2189 | Hycroft Mining Holding Corporation HYMC | $1.41B | -3.57% |
Windward Bio Group AG’s ranking market cap of $1.41B comes from the same snapshot as the rest of this site, as of November 18, 2026. It is not share price multiplied by the latest fiscal-year weighted-average share count. The ranking snapshot ($1.41B as of November 18, 2026) is FMP company-screener market cap. The historical observation ($397.76M on November 17, 2026) is FMP historical-market-capitalization for the same ticker. The live quote market cap ($1.29B) is a third FMP field, not a reason to overwrite either series. This page does not replace one series with the other.
Windward Bio Group AG (WWB) shares trade at $24.32, down 5.61% on the day, as of November 18, 2026.
Live P/E is share price divided by annual earnings per share. It is blank when earnings are missing, zero, or negative — not a 0× multiple.